Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AZN crawled time : 13:30 save search
GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study
Published: 2024-03-18 (Crawled : 13:30) - biospace.com/
ILMN | $116.64 -1.4% -1.41% 1.8M
|
Health Technology
|
| O: 0.51%
H: 2.49%
C: 1.37%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.45%
H: 0.55%
C: -0.24%
lung test cancer risk study
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
Published: 2024-01-08 (Crawled : 13:30) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 2.71%
H: 0.36%
C: 0.11%
LEXX | $2.25 -3.85% -4.0% 120K
|
Health Technology
|
| O: 0.0%
H: 8.15%
C: 1.48%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.37%
H: 1.09%
C: 0.75%
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.19%
H: 0.34%
C: 0.21%
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: 0.32%
H: 0.26%
C: -0.18%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.28%
H: 0.99%
C: 0.93%
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate, Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting
Published: 2022-03-21 (Crawled : 13:30) - biospace.com/
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -4.79%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 2.03%
H: 0.66%
C: -5.96%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
cutx-101 america genetic therapeutics biotech iot
Therapeutics for Women's Health - A Comprehensive Industry Assessment Highlighting the Key Opportunities, Pricing & Reimbursement, Players, and Strategic Recommendations - Forecast to 2026
Published: 2022-03-11 (Crawled : 13:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -2.32%
H: 2.3%
C: 0.22%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
ABBV | $164.69 0.27% 0.0% 4.5M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.22%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
health therapeutics women
Idiopathic Pulmonary Fibrosis Market to Reach $6.16 Bn, Globally, by 2030 at 7.0% CAGR: Allied Market Research
Published: 2022-02-07 (Crawled : 13:30) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 2.69%
H: 0.5%
C: -1.76%
BMY | $48.295 0.95% 0.0% 11M
|
Health Technology
|
| O: 3.7%
H: 1.64%
C: 1.24%
GLPG | News | $28.9 -1.1% -1.11% 140K
|
Health Technology
|
| O: 2.54%
H: 1.58%
C: 0.1%
FGEN | $1.165 -8.27% -9.01% 1.3M
|
Health Technology
|
| O: -1.09%
H: 9.3%
C: 8.82%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 2.54%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.14%
H: 1.01%
C: 0.87%
fibrosis research
Fortress Biotech Announces Initiation of Phase 2 Clinical Trial of Triplex for Adults Co-Infected with HIV and CMV
Published: 2021-12-16 (Crawled : 13:30) - globenewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 1.5%
H: 1.71%
C: 1.71%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: -5.34%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 2.13%
H: 1.9%
C: 1.73%
phase 2 trial biotech iot hiv infections
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for Treatment of Menkes Disease
Published: 2021-12-07 (Crawled : 13:30) - globenewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -2.48%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 7.0%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -2.08%
H: 1.18%
C: 1.13%
new drug treatment application drug therapeutics disease biotech iot submission
Akoya Biosciences to Host Inaugural Spatial Day on December 15, 2021
Published: 2021-11-22 (Crawled : 13:30) - globenewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: -0.1%
AKYA | $3.855 -1.41% -1.43% 260K
|
Professional, Scientific, and T...
|
| O: 6.15%
H: 2.32%
C: 1.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: 0.0%
bioscience
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.